PCOS Clinical Study

We are conducting a clinical drug trial for women who have Polycystic ovarian syndrome (PCOS).

PCOS is a disorder where women have elevated testosterone, irregular menstrual periods, and polycystic ovaries. Its etiology is unknown and treatment is based on symptoms.  

PCOS has the potential to cause metabolic health problems, which include an increased risk of diabetes and cardiovascular disease.

Our office has been involved with clinical drug trials for 16 years. Abbvie pharmaceutical has chosen our office as well as other sites throughout the United States to participate in a clinical drug trial for women who have PCOS. The medication in the trial is Orlissa, which is an FDA approved drug for the treatment of endometriosis. 

Those who choose to participate will receive trial related procedures and treatment for free. They will also receive compensation for their participation. Participation is always voluntary and patients can discontinue the study at anytime for any reason.  

To be eligible to participate, a woman has to be 18 to 35 years old, have irregular menstrual periods, and have evidence of elevated testosterone.  The BMI has to be 18.5 to 35.  

If you feel that you might want to participate please call my office at (702) 242-8800 and ask for someone in the research department. You may also email me at gmabeyresearch@gmail.com. 

If you wish to come in to the office and meet us and discuss the study, please call and make an appointment. There will be no charge.